Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

BACKGROUND: Evidence‐based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. METHODS AND RESULTS: Pharmacy and medical claims data from within Anthem were q...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Nelson, Adam J., Ardissino, Maddalena, Haynes, Kevin, Shambhu, Sonali, Eapen, Zubin J., McGuire, Darren K., Carnicelli, Anthony, Lopes, Renato D., Green, Jennifer B., O’Brien, Emily C., Pagidipati, Neha J., Granger, Christopher B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955303/
https://ncbi.nlm.nih.gov/pubmed/33432843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.016835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados